3 hours Why Viking Therapeutics Stock Topped the Market Today The Motley Fool
An analyst waxed bullish on the company’s leading pipeline program.
Biotech · Nasdaq 100 · S&P 500
An analyst waxed bullish on the company’s leading pipeline program.
Biotech · Nasdaq 100 · S&P 500